CD274 and neoplasm: Other study shown that patients with PD-L1 positive expression in tumor cells had better good recurrence-free survival (RFS) and OS than those with PD-L1 negative expression in tumor cells; and PD-L1 expression was found to be an independent marker for favorable RFS and OS in TNBC patients (42).